Payment overview · 2025
General Payments
$16.09
1 reported records · 1 companies
Healthcare provider profile · identity verified
Lacy Perry
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · BATESVILLE, MS · NPI 1740734680
Verified facts
What the public records show
CMS Open Payments records show Lacy Perry received $16.09 in general payments during 2025 across 1 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 77 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VIBERZI as an associated drug or biological on 11354 records involving 5020 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Viberzi by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $16.09 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.09 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $16.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
77 | 19 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VIBERZI open payments reported associated product |
CMS Open Payments — General Payments 11354 supporting records · 5020 recipient NPIs · example record 1201352948 |
Viberzi · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Potassium Chloride | Potassium Chloride | 639 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 589 | 144 |
| Gabapentin | Gabapentin | 503 | 95 |
| Atorvastatin Calcium | Atorvastatin Calcium | 447 | 94 |
| Furosemide | Furosemide | 426 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 374 | 85 |
| Quetiapine Fumarate | Quetiapine Fumarate | 361 | 40 |
| Levothyroxine Sodium | Levothyroxine Sodium | 356 | 56 |
| Omeprazole | Omeprazole | 305 | 61 |
| Mirtazapine | Mirtazapine | 239 | 40 |
| Donepezil Hcl | Donepezil Hcl | 214 | 27 |
| Metformin Hcl | Metformin Hcl | 212 | 63 |
| Carvedilol | Carvedilol | 210 | 45 |
| Meloxicam | Meloxicam | 210 | 59 |
| Lisinopril | Lisinopril | 206 | 55 |
| Eliquis | Apixaban | 201 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 199 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 193 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 192 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 185 | 27 |
| Montelukast Sodium | Montelukast Sodium | 181 | 36 |
| Losartan Potassium | Losartan Potassium | 179 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 175 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 168 | 36 |
| Famotidine | Famotidine | 164 | 34 |
| Sertraline Hcl | Sertraline Hcl | 162 | 32 |
| Divalproex Sodium | Divalproex Sodium | 151 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 148 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 143 | 22 |
| Clonazepam | Clonazepam | 136 | 18 |
| Simvastatin | Simvastatin | 133 | 27 |
| Tramadol Hcl | Tramadol Hcl | 122 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 118 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 116 | 20 |
| Allopurinol | Allopurinol | 113 | 23 |
| Mounjaro | Tirzepatide | 113 | 17 |
| Lovastatin | Lovastatin | 105 | 32 |
| Lorazepam | Lorazepam | 98 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 96 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 94 | 15 |
| Prednisone | Prednisone | 91 | 30 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 90 | 63 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 29 |
| Memantine Hcl | Memantine Hcl | 82 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 81 | 18 |
| Linzess | Linaclotide | 77 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 76 | 34 |
| Levetiracetam | Levetiracetam | 76 | 12 |
| Pregabalin | Pregabalin | 75 | 16 |
| Diazepam | Diazepam | 73 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 73 | 31 |
| Jardiance | Empagliflozin | 70 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 70 | 17 |
| Alprazolam | Alprazolam | 69 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 69 | 11 |
| Insulin Lispro | Insulin Lispro | 67 | suppressed |
| Scopolamine | Scopolamine | 66 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 65 | suppressed |
| Lamotrigine | Lamotrigine | 64 | suppressed |
| Aripiprazole | Aripiprazole | 63 | suppressed |
| Trulicity | Dulaglutide | 60 | suppressed |
| Azithromycin | Azithromycin | 59 | 50 |
| Finasteride | Finasteride | 55 | suppressed |
| Latanoprost | Latanoprost | 55 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 16 |
| Spironolactone | Spironolactone | 52 | 13 |
| Trazodone Hcl | Trazodone Hcl | 52 | suppressed |
| Digoxin | Digoxin | 51 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 49 | 17 |
| Myrbetriq | Mirabegron | 49 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Budesonide | Budesonide | 47 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 46 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 45 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 44 | 43 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 43 | suppressed |
| Ezetimibe | Ezetimibe | 42 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 42 | suppressed |
| Colchicine | Colchicine | 41 | 18 |
| Nitroglycerin Patch | Nitroglycerin | 41 | suppressed |
| Atenolol | Atenolol | 40 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Risperidone | Risperidone | 40 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 39 | 22 |
| Cephalexin | Cephalexin | 39 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 39 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 24 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 37 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Ozempic | Semaglutide | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Cefdinir | Cefdinir | 34 | 30 |
| Olanzapine | Olanzapine | 34 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 23 |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Phenobarbital | Phenobarbital | 32 | suppressed |
| Torsemide | Torsemide | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 22 |
| Celecoxib | Celecoxib | 31 | suppressed |
| Glimepiride | Glimepiride | 31 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 30 | 12 |
| Levofloxacin | Levofloxacin | 30 | 23 |
| Sucralfate | Sucralfate | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Entresto | Sacubitril/Valsartan | 29 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 23 |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 27 | suppressed |
| Ursodiol | Ursodiol | 27 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Cilostazol | Cilostazol | 25 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 25 | 17 |
| Fluconazole | Fluconazole | 25 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 25 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 24 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 24 | 19 |
| Humalog | Insulin Lispro | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | 15 |
| Ranolazine Er | Ranolazine | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | 12 |
| Nystatin | Nystatin | 22 | 16 |
| Nystop | Nystatin | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 19 | 13 |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 17 |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | 12 |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 15 |
| Dulera | Mometasone/Formoterol | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Novolog | Insulin Aspart | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | 12 |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Viberzi | Eluxadoline | 14 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 13 | suppressed |
| Fycompa | Perampanel | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | 12 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Trulance | Plecanatide | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Clarithromycin | Clarithromycin | 11 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Glucagen | Glucagon | 11 | suppressed |
| Junel Fe | Norethindrone-E.Estradiol-Iron | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 11 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.09 · 1 records | ABBVIE INC. | VRAYLAR | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error